Navigation Links
Medical Marijuana, Inc. Reports Record First Quarter 2013 Revenue and Income
Date:4/11/2013

usive use of its name. MJNA also signed a contract with CANV to outsource its manufacturing as well as its hemp production\cultivation. The transaction allowed MJNA to streamline its focus to its core industries while still allowing the company to benefit for the production, distribution and growth of the brand and its licensee.
  • PhytoSPHERE Systems proprietary extraction technology helped the Company produce cost effective, high value CBD oil with concentrations of up to 85% by volume and expects to have full scale production of a 95% plus pre CBD extract in May of this year.
  • PhytoSPHERE successfully produced its first CBG (Cannabigerol) and CBGA (Cannabigerol-Acid) containing hemp oil. Opening up an entirely new market for product development and sales, as well as wholesale raw ingredient sales opportunity. CBG and CBGA have shown to have extensive health and wellness benefits.
  • PhytoSPHERE signed additional contracts to provide for significant expansion of its hemp oil products line. Expected to more than quadruple last year's production.
  • Company expanded its US based laboratory with additional team members and equipment. MJNA actively hiring in all departments. Company signed additional lease space for its expansion.
  • Canchew CBD gum is in full scale Over the Counter product manufacturing and production. Product sales to start third week in April.
  • The Company finalized plans for Canchew biotechnologies European clinical trials beginning in 2013. MJNA provided $12 million in MJNA equity to secure its product development, clinical trials and expansion costs.
  • Rebranding started of CanChew Biotechnologies Corporate Website to be completed in April, updates include: Clinical development path with timelines and interactive update modules, additional and expanded research library.
  • Rebranding and launch started of the Canchew over the counter product sales and informational website, whic
    '/>"/>

  • SOURCE Medical Marijuana, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
    2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
    3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
    4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
    6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
    7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
    9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
    10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
    11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/26/2015)... , Feb. 26, 2015  Lyric Pharmaceuticals Inc. today ... round totaling $20.4 million. The financing, co-led by RiverVest ... participation by Aperture Venture Partners. Lyric ... David Wurtman , M.D., M.B.A., President & Chief ... Chief Medical Officer.  In 2014, Lyric closed a seed ...
    (Date:2/26/2015)... BOSTON , Feb. 26, 2015 ... ("Columbia" or "the Company"), a specialty pharmaceutical company ... health, plans to initiate a Phase II clinical ... in women undergoing transvaginal pipelle-directed endometrial biopsy in ... pre-Investigational New Drug ("IND") submission feedback from the ...
    (Date:2/26/2015)... SALT LAKE CITY , Feb. 26, 2015 /PRNewswire/ ... it has launched a "best efforts" follow-on offering of ... unit consists of one share of Series E preferred ... Series E preferred stock will be convertible into four ... will be exercisable into one share of common stock ...
    Breaking Medicine Technology:Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
    ... 23 Lixte,Biotechnology Holdings (OTC Bulletin Board: LIXT) ... Zhuang of the Surgical Neurology Branch (SNB),National Institute ... Health (NIH) and its collaborator, Lixte Biotechnology,Holdings. Inc., ... Association,of Cancer Research that its lead compound LB-1, ...
    ... First Registration Study of an Investigational Drug for Duchenne/Becker ... ... PTC Therapeutics, Inc.,(PTC), today announced the initiation of an international pivotal ... nonsense mutation. The primary objective of this registration-directed,Phase 2b trial is ...
    Cached Medicine Technology:Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research 2Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research 3PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy 2PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy 3PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy 4PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy 5
    (Date:2/26/2015)... Colorado (PRWEB) February 26, 2015 As ... millions are looking for deeper meaning, more substantial roles ... question – how do I live a life that ... 10th round of Younger Next Year Total Immersion ... revealed. This program boasts unbelievable results and jump-starts a ...
    (Date:2/26/2015)... 2015 “In the last few years, ... evolution of one of the newest hair restoration technologies ... offers a machinery that facilitates the extraction of ... scalp,” said Dr. Parsa Mohebi. , Although ARTAS had ... at which the device extracted these grafts could not ...
    (Date:2/26/2015)... Los Angeles, CA (PRWEB) February 26, 2015 ... to live stream his hair transplant contest winner’s ... and preparation, the winner Marc R., is all set to ... transplant using the ARTAS system. His procedure will be done ... Parsa Mohebi website. To watch the surgery, go to the ...
    (Date:2/26/2015)... Thousands of people in local communities nationwide ... for the Muscular Dystrophy Association during the 2015 MDA ... that will help save and improve the lives of ... Walk events unite and rally communities to raise funds ... are compromised — including everyday abilities like walking, running, ...
    (Date:2/26/2015)... February 26, 2015 PartnerTech Inc . ... & Makers Awards finalist. , The Movers ... involved in the manufacturing, processing, or distribution of tangible products ... Center. This annual event serves as Georgia’s largest local ... expected to draw more than 300 local industry and business ...
    Breaking Medicine News(10 mins):Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:Newest Technology now Available at Parsa Mohebi Hair Restoration 2Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3
    ... ordering chest CT examinations translates into positive examinations three-quarters ... study, conducted at Massachusetts General Hospital in Boston, of ... a decision support system, found that 76% of patients ... "Rising concerns about radiation risks, imaging growth and reimbursement ...
    ... A new analysis suggests the benefits of mammography screening ... 40 to 49 who are at an increased risk of ... out of every five American women. The researchers also ... to film mammography. These findings, with contributions from three national ...
    ... State University researchers have invented a protein purifier that ... The details of the invention, which appear in a ... that MSU chemists Merlin Bruening and Greg Baker,s high-performance ... step in the development of some new drugs. ...
    ... Dotinga HealthDay Reporter , MONDAY, April 30 (HealthDay ... a commonly used insecticide to unusual changes in the brain ... that the pesticide is at fault. The findings ... as chlorpyrifos, which is used to treat farm products in ...
    ... officer calling for backup while also keeping a strong hold ... a two-tier approach to fighting off a threat, new research ... the first time, the scientists managed to capture that reaction ... model of virus-infected brain cells, while also sending signals to ...
    ... Control and Prevention (CDC) found that one-third of U.S. adults ... depression. According to findings that appear today in Arthritis ... behalf of the American College of Rheumatology (ACR), anxiety is ... despite more clinical focus on the latter mental health condition. ...
    Cached Medicine News:Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 2Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 3Health News:MSU invention could help pharmaceutical industry save money 2Health News:Insecticide Linked to Brain Abnormalities in Kids 2Health News:Insecticide Linked to Brain Abnormalities in Kids 3Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 2Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 3Health News:One-third of adult Americans with arthritis battle anxiety or depression 2
    ... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
    ... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
    ... assembly allows internal or external ... coil allows rapid cool-down between ... approximately 10 C of ambient, ... only 5.7 inches wideideal for ...
    Inquire...
    Medicine Products: